Access Pharmaceuticals
About Us
Board of Directors
Senior Management
Product Programs
MuGard
Fact Sheet
MuGard.com
Order Form
Cobalamin mediated oral drug delivery
CobaCyte - Cobalamin targeted delivery
Publications
Business Development
Investor Relations
SEC Filings
Newsroom
2013
2012
2011
Contact Us
Contact
2600 Stemmons Freeway,
Suite 176
Dallas, TX 75207-2107
Tel: (214) 905-5100
Fax: (214) 905-5101
info@accesspharma.com
Sign up for news alerts!
Stock Quote
ACCP
Last Trade
0.52
Change
+0.05
Open
0.47
Bid
N/A
Ask
N/A
Volume
39730
quotes delayed at least 15 minutes
Product Programs
Select Product
MuGard
Cobalamin mediated oral drug delivery
CobaCyte - Cobalamin targeted delivery
Publications
Latest News & Events
Oral Mucositis Symposium Presentation: MASCC 2012
04.29.13
Rush University Medical Center Presents Positive MuGard Clinical Data at the Oncology Nursing Society 38th Annual Congress
03.20.13
ACCESS PHARMACEUTICALS TO HOST FOURTH QUARTER AND FISCAL YEAR INVESTOR CALL ON WEDNESDAY, APRIL 3RD AT 11:00AM ET
11.18.12
Access pharmaceuticals To Host Third Quarter Investor Call on Wednesday, November 28th
10.25.12
ACCESS PHARMACEUTICALS ANNOUNCES PRIVATE PLACEMENT FINANCING
08.23.12
Access Pharmaceuticals To Host Second Quarter Investor Call on Thursday, August 23, 2012
More News